HilleVax, Inc.
HLVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $101,747 | $651,606 | $629,985 | $576,355 |
| - Cash | $154,467 | $216,678 | $279,401 | $124,566 |
| + Debt | $24,513 | $51,193 | $36,398 | $158,461 |
| Enterprise Value | -$28,207 | $486,121 | $386,982 | $610,250 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$2,156 | -$2,252 | -$3 |
| % Margin | – | – | – | – |
| EBITDA | -$155,291 | -$132,466 | -$65,113 | -$99,561 |
| % Margin | – | – | – | – |
| Net Income | -$147,267 | -$123,566 | -$257,005 | -$85,025 |
| % Margin | – | – | – | – |
| EPS Diluted | -3 | -3.04 | -6.83 | -2.82 |
| % Growth | 1.3% | 55.5% | -142.2% | – |
| Operating Cash Flow | -$108,791 | -$86,783 | -$61,989 | -$7,295 |
| Capital Expenditures | -$522 | -$10,748 | -$6,514 | -$2,808 |
| Free Cash Flow | -$109,313 | -$97,531 | -$68,503 | -$10,103 |